Doctor of Podiatric Medicine Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Anthony Colonna

Podiatrist, Foot & Ankle Surgery Erie, PA Doctor of Podiatric Medicine

NPI 1811337603 CMS profile 218680

3330 Peach St, Suite 107, Erie, PA 16508

Open in the dashboard

General payments

$37,616

496 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Anthony Colonna of Erie, PA is reported in the CMS Open Payments database as having received $37,616 across 496 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $12,776 72
2024 General $11,629 61
2023 General $4,438 60
2022 General $591 18
2021 General $3,986 81
2020 General $1,820 93
2019 General $2,377 111

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Anthony Colonna
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Anthony Colonna were reported at $12,776. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Anthony Colonna Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $2,377 $389 $118–$1,406 $163
2020 $1,820 $191 $62–$691 $114
2021 $3,986 $329 $104–$1,341 $132
2022 $591 $419 $125–$1,611 $149
2023 $4,438 $377 $128–$1,164 $160
2024 $11,629 $394 $134–$1,168 $164
2025 $12,776 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Smith+Nephew, Inc. $22,758 340 payments
  2. Arthrex, Inc. $8,364 10 payments
  3. Mid-Atlantic Surgical Systems, LLC $1,366 14 payments
  4. Orthofix Medical, Inc. $1,356 13 payments
  5. Organogenesis Inc. $931 34 payments
  6. Kerecis Limited $490 5 payments
  7. Osiris Therapeutics Inc. $479 31 payments
  8. Integra LifeSciences Corporation $379 5 payments
  9. Misonix Inc $157 2 payments
  10. Treace Medical Concepts, Inc. $147 6 payments
  11. Other $1,189 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $12,806 466 payments
  2. Consulting Fee $11,625 3 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $6,250 3 payments
  4. Travel and Lodging $5,719 22 payments
  5. Education $1,217 2 payments
Products named General payments · program years 2019–2025
  1. Versajet $16,054 23 payments
  2. GRAFIX PL Other Advanced Wound Management $3,473 106 payments
  3. TrueLok $2,456 21 payments
  4. GRAFIX PL Other Advanced Wound Management $1,746 90 payments
  5. Stravix $1,448 67 payments
  6. STRAVIX PL $1,286 13 payments
  7. GrafixPL $1,140 56 payments
  8. OASIS $1,082 7 payments
  9. GRAFIX Other Advanced Wound Management $985 5 payments
  10. GRAFIX Other Advanced Wound Management $929 51 payments
  11. Other $8,769 217 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 9 drugs

Part D claims

280

Median for Podiatry: 160

Drug cost

$4,731

Median for Podiatry: $2,368

Branded share of claims

18.2%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Pregabalin Generic 13 $1,113
Gabapentin Generic 44 $940
Ammonium Lactate Generic 66 $891
Clotrimazole-Betamethasone Clotrimazole/Betamethasone Dip Brand 23 $806
Ciclopirox Generic 24 $449
Mupirocin Generic 46 $268
Cephalexin Generic 17 $125
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 28 $121
Prednisone Generic 19 $18

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 75 billing codes

Paid by Medicare

$137,230

Of which drugs: $75,865

Medicare patients

302

Average age 72

Services billed

1,254

148 women, 154 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Diabetes 43%
Depression 28%
Chronic kidney disease 25%
Ischemic heart disease 24%
Heart failure 20%
Atrial fibrillation 16%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 35 82 $62
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 33 74 $7

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

2 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
DIFICID
  • Merck Sharp & Dohme Corporation $23
$23 — —
VERQUVO
  • Merck Sharp & Dohme Corporation $20
$20 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

496 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record